ID23675A - Senyawa-senyawa yang mempunyai aktivitas neuronal - Google Patents

Senyawa-senyawa yang mempunyai aktivitas neuronal

Info

Publication number
ID23675A
ID23675A IDW20000402A ID20000402A ID23675A ID 23675 A ID23675 A ID 23675A ID W20000402 A IDW20000402 A ID W20000402A ID 20000402 A ID20000402 A ID 20000402A ID 23675 A ID23675 A ID 23675A
Authority
ID
Indonesia
Prior art keywords
compounds
neuronal activities
neuronal
activities
Prior art date
Application number
IDW20000402A
Other languages
English (en)
Indonesian (id)
Inventor
Mccaferey Patricia
Perry M Novak
Mullican Michael
Original Assignee
Vertex Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/085,441 external-priority patent/US6268384B1/en
Application filed by Vertex Pharma filed Critical Vertex Pharma
Publication of ID23675A publication Critical patent/ID23675A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
IDW20000402A 1997-08-29 1998-08-27 Senyawa-senyawa yang mempunyai aktivitas neuronal ID23675A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92083897A 1997-08-29 1997-08-29
US09/085,441 US6268384B1 (en) 1997-08-29 1998-05-27 Compounds possessing neuronal activity

Publications (1)

Publication Number Publication Date
ID23675A true ID23675A (id) 2000-05-11

Family

ID=26772724

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000402A ID23675A (id) 1997-08-29 1998-08-27 Senyawa-senyawa yang mempunyai aktivitas neuronal

Country Status (17)

Country Link
US (1) US7109215B2 (US06559137-20030506-C00039.png)
EP (1) EP1007521A1 (US06559137-20030506-C00039.png)
JP (1) JP2001514177A (US06559137-20030506-C00039.png)
CN (1) CN100436447C (US06559137-20030506-C00039.png)
AU (1) AU766579B2 (US06559137-20030506-C00039.png)
BR (1) BR9811923A (US06559137-20030506-C00039.png)
CA (1) CA2300134A1 (US06559137-20030506-C00039.png)
ID (1) ID23675A (US06559137-20030506-C00039.png)
IL (1) IL134536A0 (US06559137-20030506-C00039.png)
IN (1) IN191127B (US06559137-20030506-C00039.png)
IS (1) IS5379A (US06559137-20030506-C00039.png)
NO (1) NO321790B1 (US06559137-20030506-C00039.png)
NZ (1) NZ502820A (US06559137-20030506-C00039.png)
PL (1) PL195273B1 (US06559137-20030506-C00039.png)
SG (1) SG129998A1 (US06559137-20030506-C00039.png)
TW (1) TW570919B (US06559137-20030506-C00039.png)
WO (1) WO1999010340A1 (US06559137-20030506-C00039.png)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6514686B2 (en) 1997-04-28 2003-02-04 The University Of British Columbia Method and composition for modulating amyloidosis
EA200001247A1 (ru) * 1998-06-03 2001-08-27 Джи Пи Ай Нил Холдингс, Инк. N-связанные сульфонамиды n-гетероциклических карбоновых кислот или изостеры карбоновых кислот
US6339101B1 (en) * 1998-08-14 2002-01-15 Gpi Nil Holdings, Inc. N-linked sulfonamides of N-heterocyclic carboxylic acids or isosteres for vision and memory disorders
US6333340B1 (en) * 1998-08-14 2001-12-25 Gpi Nil Holdings, Inc. Small molecule sulfonamides for vision and memory disorders
US6300341B1 (en) 1998-09-30 2001-10-09 The Procter & Gamble Co. 2-substituted heterocyclic sulfonamides
EP1196387A1 (en) 1999-07-06 2002-04-17 Vertex Pharmaceuticals Incorporated Azo amino acid derivatives for the treatment of neurological diseases
AU6073300A (en) 1999-07-06 2001-01-22 Vertex Pharmaceuticals Incorporated N-heterocyclic derivatives with neuronal activity
AU5912800A (en) * 1999-07-06 2001-01-22 Vertex Pharmaceuticals Incorporated Beta-amino acid derivatives for the treatment of neurological diseases
EP1207882A4 (en) * 1999-07-30 2003-03-19 Vertex Pharma DERIVATIVES OF ACYCLIC AND CYCLIC AMINES
EP1202970A1 (en) * 1999-07-30 2002-05-08 Vertex Pharmaceuticals Incorporated Cyclic amine derivatives for the treatment of neurological diseases
WO2001012622A1 (en) * 1999-08-18 2001-02-22 Schering Aktiengesellschaft Piperidine and pyrrolidine derivatives displaying neuronal activity
US6818643B1 (en) 1999-12-08 2004-11-16 Bristol-Myers Squibb Company Neurotrophic bicyclic diamides
JP2002068973A (ja) * 2000-06-16 2002-03-08 Meiji Milk Prod Co Ltd 幹細胞分化誘導促進剤
ES2324293T3 (es) * 2002-10-03 2009-08-04 Vertex Pharmaceuticals Incorporated Derivados de piperacina y piperidina para el tratamiento de enfermedades neurologicas.
WO2005033068A1 (en) * 2003-10-06 2005-04-14 Oy Juvantia Pharma Ltd Somatostatin receptor 1 and/or 4 selective agonists and antagonists
EP1720564A1 (en) * 2004-02-20 2006-11-15 Rinat Neuroscience Corp. Methods of treating obesity or diabetes using nt-4/5
CA2637707A1 (en) * 2006-02-02 2007-08-09 Rinat Neuroscience Corporation Methods for treating obesity by administering a trkb antagonist
US20070248611A1 (en) * 2006-02-02 2007-10-25 Pfizer Inc Methods wanted for treating unwanted weight loss or eating disorders by administering a trkb agonist
JP2010513461A (ja) * 2006-12-20 2010-04-30 ライナット ニューロサイエンス コーポレイション 自己免疫障害を治療するためのＴｒｋＢアゴニスト
US9152929B2 (en) 2013-01-23 2015-10-06 Splunk Inc. Real time display of statistics and values for selected regular expressions
TWI744300B (zh) * 2016-03-23 2021-11-01 里爾中央醫學中心 改良性熱處理的血小板顆粒裂解液在製備用於治療神經系統疾病的組合物的用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4792555A (en) * 1987-03-20 1988-12-20 American Home Products Corporation Phospholipase A2 inhibitors
MX9202466A (es) * 1991-05-24 1994-06-30 Vertex Pharma Compuestos inmunosupresores novedosos.
NZ314207A (en) * 1992-09-28 2000-12-22 Vertex Pharma 1-(2-Oxoacetyl)-piperidine-2-carboxylic acid derivatives as multi drug resistant cancer cell sensitizers
US5686469A (en) * 1993-02-09 1997-11-11 Miles Inc. Aminomethylene derivaties as immunosuppressants
US5744485A (en) * 1994-03-25 1998-04-28 Vertex Pharmaceuticals Incorporated Carbamates and ureas as modifiers of multi-drug resistance
US5721256A (en) * 1997-02-12 1998-02-24 Gpi Nil Holdings, Inc. Method of using neurotrophic sulfonamide compounds

Also Published As

Publication number Publication date
CN1271354A (zh) 2000-10-25
NO321790B1 (no) 2006-07-03
TW570919B (en) 2004-01-11
PL338791A1 (en) 2000-11-20
NZ502820A (en) 2002-10-25
US7109215B2 (en) 2006-09-19
SG129998A1 (en) 2007-03-20
JP2001514177A (ja) 2001-09-11
CN100436447C (zh) 2008-11-26
IL134536A0 (en) 2001-04-30
US20020013351A1 (en) 2002-01-31
AU766579B2 (en) 2003-10-16
IN191127B (US06559137-20030506-C00039.png) 2003-09-27
CA2300134A1 (en) 1999-03-04
AU8923698A (en) 1999-03-16
BR9811923A (pt) 2000-08-15
PL195273B1 (pl) 2007-08-31
IS5379A (is) 2000-02-18
WO1999010340A1 (en) 1999-03-04
NO20000953L (no) 2000-05-02
EP1007521A1 (en) 2000-06-14
NO20000953D0 (no) 2000-02-25

Similar Documents

Publication Publication Date Title
ID23675A (id) Senyawa-senyawa yang mempunyai aktivitas neuronal
ID28110A (id) Surfaktan alkilbenzenasulfonat yang disempurnakan
ID26509A (id) Komponen-komponen yang mengandung tetrahidrolipstatin
DE69841276D1 (de) Atemschutzmaske
ID26330A (id) Polipeptida-polipeptida yang bergantung vitamin k yang dimodifikasi
ID17140A (id) Ritsleting yang dicetak
DE69838271D1 (de) Verbesserte Atemschutzmaske
ID23498A (id) Peranti inhalasi
ID23494A (id) Benda-benda penyerap yang mempunyai komponen-komponen yang dapat diambil
DK0970584T3 (da) Videokonferencesystem
FI973544A0 (fi) Foerfarande foer att foermedla meddelanden
FI973718A0 (fi) Foerbaettrat foerfarande foer att byta basstation
DE59805279D1 (de) Gurtschloss
ID26317A (id) Formulasi pelepasan yang diperpanjang
ZA987478B (en) Compounds possessing neuronal activity
DE69819177D1 (de) Gurtschloss
DE69815390D1 (de) Neuronale netzwerke
DE69811246D1 (de) Elektrowärmegeräte
ID16981A (id) Konsentrat-konsentrat mutiara yang encer
ID24431A (id) Lateks-lateks yang tahan gosokan
DE59814478D1 (de) Kehlmaschine
ID19990A (id) Peralatan penyalur yang memiliki unit penyaring yang ditingkatkan
DE69728187D1 (de) Schnalle
NO995492L (no) Algicider
FI970538A0 (fi) Rengoeringsanordning foer filter i dammfiltreringsanordning